Development of CRISPR-Cas genome and epigenome engineering tools towards retinal degenerations by Kantor, A

CANCER IN PATIENTS RECEIVING LONG-TERM DIALYSIS TREATMENT by Kantor, A, Hoover, R, Kinlen, L, Fraumeni, J

Cancer in patients receiving long-term dialysis treatment. by Kantor, A, Hoover, R, Kinlen, L, McMullan, MR, Fraumenti, J

Non-viral delivery of CRIPSR/Cas cargo to the retina using nanoparticles: current possibilities, challenges, and limitations by Salman, A, Kantor, A, McClements, ME, Marfany, G, Trigueros, S, MacLaren, RE

Is subretinal AAV gene replacement still the only viable treatment option for choroideremia? by Han, RC, Fry, LE, Kantor, A, McClements, ME, Xue, K, MacLaren, RE

Genome-editing strategies for treating human retinal degenerations by Quinn, J, Musa, A, Kantor, A, McClements, ME, Cehajic-Kapetanovic, J, MacLaren, RE, Xue, K